FDA Import Refusal 004-0211549-8/11/1 — GlaxoSmithKline Biologicals SA

GlaxoSmithKline Biologicals SA — FEI 3002875226

The FDA refused shipment 004-0211549-8/11/1 from GlaxoSmithKline Biologicals SA (Belgium) on September 13, 2017. The refused product falls under Drugs and Biologics — ALBUMIN. Cited charge: 71 This firm has 5 or more other import refusals on record.